Twice-daily vs. Once-daily dolutegravir in patients with human immunodeficiency virus-tuberculosis coinfection receiving rifampicin-based tuberculosis therapy

Sanghyuk S. Shin, Chawangwa Modongo, Nicola M. Zetola

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)242-243
Number of pages2
JournalClinical Infectious Diseases
Issue number1
StatePublished - Jul 1 2020
Externally publishedYes

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this